Sublingual versus injective immunotherapy in grass pollen allergic patients: A double blind (double dummy) study

Clinical and Experimental Allergy

Volumn 26, Issue 11, 1996, Pages 1253-1261

  Quirino, T ^a   Iemoli, E ^a   Siciliani, E ^a   Parmiani, S ^b,c   Milazzo, F ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b ALK Abello SpA   (Italy)

^c Dipartimento Scientifico   (Italy)

Author keywords

Grass pollen allergy; Injective immunotherapy; Skin reactivity; Specific IgE; Specific IgG4; Sublingual immunotherapy; Total specific IgG

Indexed keywords

ALLERGEN; IMMUNOGLOBULIN G4; PLACEBO;

ADULT; ALLERGY; ARTICLE; ASTHMA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; GRASS POLLEN; HUMAN; IMMUNOTHERAPY; MALE; POLLEN ALLERGY; PRIORITY JOURNAL; SKIN TEST; SUBLINGUAL DRUG ADMINISTRATION;

ADMINISTRATION, SUBLINGUAL; ADOLESCENT; ADULT; ALLERGENS; ASTHMA; CONJUNCTIVITIS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; IMMUNOTHERAPY; INJECTIONS; MALE; POLLEN; RHINITIS; SKIN TESTS;

EID: 0029860767     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2222.1996.tb00522.x     Document Type: Article

References (33)

1. Price JF, Warner JO, Hey EN, Turner MW, Soothill JF. A controlled trial of hyposensitization with absorbed Dermatophagoides pteronyssinus antigen in childhood asthma. Clin. Allergy 1984; 14:209-19.
2. Malling HJ, Dreborg S, Weeke B. Diagnosis and immunotherapy of mould allergy. V. Clinical efficacy and side-effects of immunotherapy with Cladosporium herbarum. Allergy 1986; 41:507-19.
3. Reid MJ, Moss RB, Hsu Y-P et al. Seasonal asthma in northern California: allergic causes and efficacy of immunotherapy. J Allergy Clin Immunol 1986; 78:590.
4. Bousquet J, Hejjaoui A, Clauzel AM et al. Specific immunotherapy with standardized Dermatophagoides pteronyssinus extract. II. Prediction of efficacy immunotherapy. J Allergy Clin Immunol 1988; 82: 971-7.
5. Bousquet J, Maash HJ, Hejjaoui A et al. Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids. III. Efficacy and safety of unfractionated and high-molecular-weight preparations in rhinoconjunctivitis and asthma. J Allergy Clin Immunol 1989; 84:546-56.
6. Horst M, Hejjaoui A, Horst V, Michel F-B, Bousquet J. Double-blind, placebo-controlled rush immunotherapy with a standardized Alternaria extract. J Allergy Clin Immunol 1990; 85:460-72.
7. Lockey RF, Benedict LM, Turkeltaub PC, Bukantz SC. Fatalities from immunotherapy (IT) and skin testing (ST). Allergy Clin Immunol 1987; 79:660-77.
8. Malling MJ, Weeke B. Immunotherapy position paper. Allergy 1993; (Suppl.) 48.
9. Kemp JP. Antihistamines is there anything safe to prescribe? Ann All 1992; 69:276-80.
10. Holt PG, Vines J, Britten D. Sublingual allergen administration. I. Selective suppression of IgE production in rats by high allergen doses. Clin Allergy 1988; 18:229-34.
11. Van Nickerk CH, De Wet JI. Efficacy of grass-maize pollen oral immunotherapy in patients with seasonal hay-fever: a double-blind study. Clin Allergy 1987; 17:507-13..
12. Cooper PJ, Darbyshire D, Nunn AJ, Warner JO. A controlled trial of oral hyposensitization in pollen asthma and rhinitis in children. Clin Allergy 1984; 14:541-50.
13. Bjorksten B, Moller C, Broberger U et al. Clinical and immunological effects of oral immunotherapy with a standardized birch pollen extract. Allergy, 1986; 41:290-5.
14. Taudorf E, Laursen LC, Lanner A et al. Oral immunotherapy in birch pollen hay fever. J Allergy Clin Immunol 1987; 80:153-61.
15. Bjorksten B, Dewdney JM. Oral immunotherapy in allergy is it effective? Clinical Allergy 1987; 17:91-4.
16. Mosbech H, Dreborg S, Madsen F et al. High dose grass pollen tablets used for hyposensitization in hay fever patients. A one-year double-blind placebo-controlled study. Allergy 1987; 42:451-5.
17. Taudorf E, Weeke B. Orally administered grass pollen. Allergy 1983; 38:561-4.
18. Giovane AL, Bardare M, Passalacqua G et al. A three-year double-blind placebo-controlled study with specific oral immunotherapy to Dermatophagoides: evidence of safety and efficacy in paediatric patients. Clin Exper Allergy 1993; 24: 53-9.
19. Scadding GK, Brostoff J. Low dose sublingual therapy in patients with allergic rhinitis due to house dust mite. Clinical Allergy 1986; 16:483-91.
20. Tari MG, Mancino M, Monti G. Efficacy of sublingual immunotherapy in patients with rhinitis and asthma due to house dust mite. Allergol et Immunopathol 1990; 18(5): 277-84.
21. Novembre E, Marano E, Bernardini R et al. Studio controllato sull'immunoterapia per via sublinguale nel trattamento dell'asma allergico del bambino. Riv Ital Pediatr 1991; 17: 75-8.
22. Sabbah A, Hassoun S, Le Seilin J, Andre C, Sicard H. A double-blind, placebo-controlled trial by the sublingual route of immunotherapy with a standardized grass pollen extract. Allergy 1994; 49:309-13.
23. Nelson HS, Oppenheimer J, Vatsia GA, Buchmeier A. A double-blind, placebo-controlled evaluation of sublingual immunotherapy with standardized cat extract. J All Clin Immunol 1993; 92:229-36.
24. Duan SQ, Fu YX, Leng X, Ye ST. A double-blind trial of oral immunotherapy for Artemisia pollen asthma with evaluation of bronchial response to the pollen allergen and serum-specific IgE antibody. Ann Allergy 1990; 64:27-31.
25. Errigo E, Canonica GW, Corsico R et al. (Commissione SIAIC) Position Statement 'Memorandum' sull'immunoterapia specifica - Edizione 1991. Giorn It Allergol Immunol Clin 1991; 1:99-114.
26. Brighton WB, Topping MD, Henocq E. Activity units for allergen extracts. Clin Allergy 1979; 9:591-6.
27. Carreira J, Rubio M, Herrero T et al. Collaborative clinical assay of the biological potency of allergen skin-test extracts. Clin Allergy 1984; 14:503-7.
28. Carreira J, Lombardero M, Ventas P. New developments in in vitro methods. Quantification of clinically relevant allergens in mass units. Arbeiten aus dem Paul-Ehrlich-Institut (Bundesamt für Sera und Impfstoffe). Stuttgart: Gustav Fischer Verlag, 1994.
29. Valovirta E, Viander M, Koivikko A, Vanto T, Ingemann L. Immunotherapy in allergy to dog. Immunologic and clinical findings of a double-blind study. Ann All 1986; 57:173
30. Ohman JL, Findlay ST, Leiterman KM. Immunotherapy in cat-induced asthma. Double-blind trial with evaluation of in vivo and in vitro responses. J All Clin Immunol 1984; 74:230-9.
31. Bousquet J, Calvayrac P, Guerin B et al. Immunotherapy with standardized Dermatophagoides pteronyssinus extract. I. In vivo and in vitro parameters after a short course of treatment. J All Clin Immunol 1985; 76:734-44.
32. Rak S, Lowhagen O, Venge P. The effect of immunotherapy on bronchial hyperresponsiveness and eosinophil cationic protein (ECP) in pollen-allergic patients. J All Clin Immunol 1988; 82:470-80.
33. Armentia-Medina A, Blanco-Quiros A, Martin Santos JM et al. Rush immunotherapy with a standardized Bermuda grass pollen extract. Ann Allergy 1989; 63:127-35.